Pathogenic Concepts in Pulmonary Arterial Hypertension Revisited: A Multigenerational Perspective

The rapid advancement of next-generation omics platforms, bioinformatic data analysis, and novel imaging techniques is transforming biomedical research, especially in pulmonary hypertension. These cutting-edge tools generate vast data, leading to innovative therapeutic and diagnostic possibilities, such as personalized medicine and patient-specific risk stratification. However, while embracing new technologies, it is crucial to integrate decades of hypothesis-driven research with emerging discovery platforms to avoid redundant efforts and enhance scientific progress. At the 2024 American Thoracic Society conference, senior and junior investigators in vascular biology, pulmonary hypertension, and right heart failure engaged in pro and con debates on research paradigms. These discussions explored how evolving disease frameworks fit within the context of traditional research, emphasizing the balance between newer multiomics approaches and classical hypothesis-driven science. Three key objectives were addressed: <i>1</i>) integrating unbiased analytic methods with traditional frameworks, <i>2</i>) interpreting new multiomics findings within known pathobiological pathways, and <i>3</i>) reviewing modern imaging methods for the right ventricle to improve disease understanding. Although omics approaches offer a broad, integrative view and support personalized medicine, they present challenges, such as managing large datasets and ensuring effective clinical translation. Conversely, traditional reductionist approaches, focusing on known genetic alterations and signaling pathways, have led to significant breakthroughs, including the development of current therapies. Combining both approaches holds great potential to drive future discoveries and develop more effective treatments for pulmonary hypertension, a goal that can be achieved only through coordinated, transdisciplinary teams of investigators with diverse skillsets and knowledge working together to advance the field.

Authors

Institutions

Publication Details

Journal
American Journal of Respiratory Cell and Molecular Biology
Published
2025-03-28
DOI
https://doi.org/10.1165/rcmb.2024-0519ps
Citations
1
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pathogenic Concepts in Pulmonary Arterial Hypertension Revisited: A Multigenerational Perspective

Grażyna Kwapiszewska, Paul M. Hassoun, Edda Spiekerkoetter, Catherine E. Simpson et al.
1 citations
American Journal of Respiratory Cell and Molecular Biology
Pulmonary Hypertension Research and Treatments
1.52
article

Pathogenic Concepts in Pulmonary Arterial Hypertension Revisited: A Multigenerational Perspective

Grażyna Kwapiszewska, Paul M. Hassoun, Edda Spiekerkoetter, Catherine E. Simpson, Marlene Rabinovitch, Kenzo Ichimura, Marc Humbert, Christopher Rhodes
article en
1 citations

Abstract

The rapid advancement of next-generation omics platforms, bioinformatic data analysis, and novel imaging techniques is transforming biomedical research, especially in pulmonary hypertension. These cutting-edge tools generate vast data, leading to innovative therapeutic and diagnostic possibilities, such as personalized medicine and patient-specific risk stratification. However, while embracing new technologies, it is crucial to integrate decades of hypothesis-driven research with emerging discovery platforms to avoid redundant efforts and enhance scientific progress. At the 2024 American Thoracic Society conference, senior and junior investigators in vascular biology, pulmonary hypertension, and right heart failure engaged in pro and con debates on research paradigms. These discussions explored how evolving disease frameworks fit within the context of traditional research, emphasizing the balance between newer multiomics approaches and classical hypothesis-driven science. Three key objectives were addressed: <i>1</i>) integrating unbiased analytic methods with traditional frameworks, <i>2</i>) interpreting new multiomics findings within known pathobiological pathways, and <i>3</i>) reviewing modern imaging methods for the right ventricle to improve disease understanding. Although omics approaches offer a broad, integrative view and support personalized medicine, they present challenges, such as managing large datasets and ensuring effective clinical translation. Conversely, traditional reductionist approaches, focusing on known genetic alterations and signaling pathways, have led to significant breakthroughs, including the development of current therapies. Combining both approaches holds great potential to drive future discoveries and develop more effective treatments for pulmonary hypertension, a goal that can be achieved only through coordinated, transdisciplinary teams of investigators with diverse skillsets and knowledge working together to advance the field.

American Journal of Respiratory Cell and Molecular BiologyVol. 73(2)
Johns Hopkins University (US), Inserm (FR), Palo Alto University (US), Medical University of Graz (AT), Université Paris-Saclay (FR), Johns Hopkins Medicine (US), Pulmonary Vascular Research Institute (GB), Pulmonary and Allergy Associates (US), German Center for Lung Research (DE), Center for Vascular Biology Research (US), Pediatrics and Genetics (US), Cardio-Pulmonary Institute (DE), Bicêtre Hospital (FR), Imperial College London (GB), Stanford University (US)
Zero hunger
Openalex Percentile: Top 20%
Pulmonary Hypertension Research and Treatments
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.